Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10637/7721
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.creator | Ramos González, Ana | - |
dc.creator | Martínez Alcázar, María Paz | - |
dc.creator | Zapico Rodríguez, José María | - |
dc.creator | Pascual-Teresa Fernández, Beatriz de | - |
dc.creator | Fabre, Benjamin | - |
dc.creator | Filipiak, Kamila | - |
dc.date | 2013 | es |
dc.date.accessioned | 2015-09-26T04:00:14Z | - |
dc.date.available | 2015-09-26T04:00:14Z | - |
dc.date.issued | 2013-09-26 | - |
dc.identifier | 000000625343 | es |
dc.identifier.uri | http://hdl.handle.net/10637/7721 | - |
dc.description | En: Organic and Biomolecular Chemistry. EISSN. 1477-0539. 2013, 11, 6623-6641, doi: 10.1039/c3ob41046c | es |
dc.description.abstract | Water solubility is a key aspect that needs to be addressed to obtain druglike compounds. In an effort to improve the water solubility of our recently reported nanomolar matrix metalloproteinase type 2 (MMP10 2) inhibitors based on triazole-substituted hydroxamates, we synthesized a new series of -sulfone, - tetrahydropyran and -piperidine, -sulfone clicked hydroxamates and determined their inhibitory activities against both MMP-2 and MMP-9. The best results were found for 13e, a water-soluble compound that displays a low nanomolar activity against MMP-2 and is 26-fold less active against MMP9. This finding allowed us to pursue in vitro permeability through Caco-2 monolayer and open the 15 possibility for carrying out further preclinical investigations. Docking and MD simulations have been performed in order to rationalize the biological results. The inhibitory activity of this compound against a panel of ten MMPs was determined showing an interesting MMP-2/MMP-1,-8,-14 selectivity profile. The cytotoxicity and anti-invasive activity of the compounds on highly metastatic human fibrosarcoma tumor cells (HT1080) were determined, showing, at 10 M concentration, a decrease in cell invasiveness up to 20 80 %. | en_EN |
dc.format | application/pdf | es |
dc.language.iso | en | es |
dc.relation | Financiado con cargo a proyectos de I+D nacional con referencias (SAF2008-00945, CTQ2011-24741, CTQ2007-105 63226, and SAF2011-28350). | es |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | es |
dc.subject | Metaloproteínas | es |
dc.subject | Análisis | - |
dc.title | Progress towards water-soluble triazole-based selective MMP-2 inhibitors. | es |
dc.type | Artículo | es |
dc.description.version | Post-print del autor | es |
europeana.dataProvider | UNIVERSIDAD SAN PABLO CEU | - |
europeana.isShownAt | http://hdl.handle.net/10637/7721 | - |
europeana.object | http://repositorioinstitucional.ceu.es/visor/libros/625343/thumb_europeana/625343.jpg | - |
europeana.provider | Hispana | - |
europeana.rights | http://creativecommons.org/publicdomain/zero/1.0/ | - |
europeana.type | TEXT | - |
dc.centro | Universidad San Pablo-CEU | - |
Aparece en las colecciones: | Facultad de Farmacia |
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.